Skip to main content

Dr. Reddy’s Recalls Prescription Drug Blister Packages Due to Risk of Poisoning

  • Recalled Dr. Reddy’s Imatinib Mesylate Tablets 100 mg
  • Recalled Dr. Reddy’s Imatinib Mesylate Tablets 100 mg
  • Recalled Dr. Reddy’s Imatinib Mesylate Tablets 400 mg
  • Recalled Dr. Reddy’s Imatinib Mesylate Tablets 400 mg
  • Recalled Dr. Reddy’s Pregabalin Capsules 50 mg
  • Recalled Dr. Reddy’s Pregabalin Capsules 50 mg
  • Recalled Dr. Reddy’s Pregabalin Capsules 75 mg
  • Recalled Dr. Reddy’s Pregabalin Capsules 75 mg
  • Recalled Dr. Reddy’s Pregabalin Capsules 100 mg
  • Recalled Dr. Reddy’s Pregabalin Capsules 100 mg
  • Recalled Dr. Reddy’s Pregabalin Capsules 150 mg
  • Recalled Dr. Reddy’s Sevelamer Carbonate Tablets 800 mg
  • Recalled Dr. Reddy’s Sevelamer Carbonate Tablets 800 mg
  • Recalled Dr. Reddy’s Tadalafil Tablets 5 mg
  • Recalled Dr. Reddy’s Tadalafil Tablets 5 mg
  • Recalled Dr. Reddy’s Tadalafil Tablets 20 mg
  • Recalled Dr. Reddy’s Tadalafil Tablets 20 mg
Name of Product:
Imatinib Mesylate Tablets 100 mg, Imatinib Mesylate Tablets 400 mg, Pregabalin Capsules 50 mg, Pregabalin Capsules 75 mg, Pregabalin Capsules 100 mg, Pregabalin Capsules 150 mg, Sevelamer Carbonate Tablets 800 mg, Tadalafil Tablets 5 mg and Tadalafil Tablets 20 mg
Hazard:

The products are prescription medications that were labeled and distributed by Dr. Reddy’s for institutional use only.  The prescription medications were distributed by third party wholesalers to retail pharmacies and could have been dispensed to consumers.  The packaging of the products is not child resistant and can pose a risk of poisoning if the contents are swallowed by young children.

Remedy:
Refund
Recall Date:
February 25, 2021
Units:

About 21,400

Consumer Contact

Dr. Reddy’s toll-free at 888-375-3784 from 8 a.m. to 8 p.m. ET Monday through Friday, or online at www.drreddys.com and click on “Recall” for more information.  Report incidents related to children accessing or ingesting these prescription medications to www.SaferProducts.gov.  Report adverse events, medication errors, and quality problems related to the use of these products to FDA’s MedWatch Adverse Event Reporting Program either online at www.fda.gov/medwatch/report.htm, download the form at www.fda.gov/MedWatch/getforms.htm or call 800-332-1088 to request a reporting form, then complete and submit by regular mail, and return to the address on the pre-addressed form, or submit by fax to 800-FDA-0178.

Recall Details

Description:

This recall involves blister packages of prescription medications.  The name and strength of the medication, “For Institutional Use only,” “Rx Only,” lot number and expiration date are printed on the outside of the package as well as on the individual blister units.  The Dr. Reddy’s logo and NDC number are printed on the outside of the package.  The recalled medications include the following:

Recalled Prescription Drugs

 

NDC Numbers Carton Configurations Lot Numbers Expiration Dates
Imatinib Mesylate Tablets 100 mg 43598-344-31

 

3 blister cards of 10 tablets

 

H2000138

 

2022-0630
Imatinib Mesylate Tablets 400 mg 43598-345-31 3 blister cards of 10 tablets H2000127 2022-0630
Pregabalin

Capsules 50 mg

43598-292-66 5 blister cards of 10 capsules T900876 2021-0630
Pregabalin Capsules 75 mg 43598-293-66 5 blister cards of 10 capsules T901021 2021-0731
Pregabalin

Capsules 100 mg

43598-294-66 5 blister cards of 10 capsules T901022 2021-0731
Pregabalin

Capsules 150 mg

43598-295-66 5 blister cards of 10 capsules T901023 2021-0731
Sevelamer Carbonate

Tablets 800 mg

55111-789-11 4 blister cards of 25 tablets T801003, T000009, T900221 2020-1031, 2021-1231, 2021-0228
Tadalafil

Tablets 5 mg

43598-575-31 3 blister cards of 10 tablets T000376 2022-0131
Tadalafil

Tablets 20 mg

43598-573-31 3 blister cards of 10 tablets T000425 2022-0228

 

Remedy:

Consumers should immediately store the recalled medications in a safe location out of reach of children and contact Dr. Reddy’s for a full refund.

Incidents/Injuries:

No incidents or injuries have been reported.

Sold At:
Beginning in 2018, Dr. Reddy’s sold the recalled medications to wholesalers. Ultimately, these medications could have been sold to consumers at retail pharmacies in the United States at prices varying based on quantities prescribed, health insurance terms, and other factors.
Manufacturer(s):
Dr. Reddy’s Laboratories, Ltd., of India
Importer(s):

Dr. Reddy’s Laboratories, Inc., of Princeton, N.J.

Manufactured In:
India
Recall number:
21-089

Note: Individual Commissioners may have statements related to this topic. Please visit www.cpsc.gov/commissioners to search for statements related to this or other topics.

Choose Your Recall Emails Get Notified About Each Recall via Email.

Related Recalls

Recalled Aprepitant Capsules 125 mg – NDC 0781-2323-68 – Carton
Sandoz Recalls Aprepitant Capsules and Lidocaine and Prilocaine Cream Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

The recalled prescription drugs and products that contain lidocaine must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

Meguiar’s Heavy Duty Headlight Sealant (Product #G2402)
Meguiar’s Recalls Headlight Sealant Due to Failure to Meet Child Resistant Packaging Requirements; Risk of Poisoning

The recalled headlight sealant contains low-viscosity hydrocarbons which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging for the products does not meet federal child resistant packaging requirements, posing a risk of poisoning if the contents are swallowed by young children.

Recalled FUUL 1.9L Pure Liquid Paraffin Lamp Oil
FHS Retail Recalls FUUL Lamp Oil Products Due to Failure to Meet Child-Resistant Packaging Requirement and Violation of FHSA Labeling Requirement; Poisoning Risk to Children

The product contains low-viscosity petroleum distillates which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act (PPPA). The packaging of the product is not child resistant. Petroleum distillates can get into the lungs causing chemical pneumonia and/or pulmonary damage which can be fatal. In addition, the label on the products violates the Federal Hazardous Substance Act (FHSA) by omitting mandatory information on the packaging.

Recalled Roots & Harvest Wide Mouth Pint Canning Jars
Roots & Harvest Wide Mouth Pint Canning Jars Recalled by LEM Products Distribution Due to Laceration Hazard

Pieces of glass can be found in some of the recalled jars, posing a laceration hazard to consumers.

Recalled Mohnark Pharmaceuticals Lidocaine 4% Topical Anesthetic Cream packaging
Mohnark Pharmaceuticals Recalls Lidocaine Topical Anesthetic Cream Due to Failure to Meet Child-Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)

The product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a risk of poisoning to young children if they ingest the anesthetic cream.

Recalled Walgreens Pain Reliever Acetaminophen 500 mg, 150 Count Bottle
Aurohealth Recalls Walgreens Brand Acetaminophen Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

The recalled over-the-counter products contain the regulated substance acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

About the U.S. CPSC

The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risk of injury or death associated with the use of thousands of types of consumer products. Deaths, injuries, and property damage from consumer product-related incidents cost the nation more than $1 trillion annually. CPSC's work to ensure the safety of consumer products has contributed to a decline in the rate of injuries associated with consumer products over the past 50 years.

Federal law prohibits any person from selling products subject to a Commission ordered recall or a voluntary recall undertaken in consultation with the CPSC.

For lifesaving information:
Report an unsafe product